Application of Experimental Therapies in Lung Cancer
Death usually occurs not because of breathing difficulties caused by the growing cancer, but because the position of the lungs in the circulatory system is easy to make the cancer spread throughout the body. Metastases dissemination towards the brain and other critical parts of the one who caused the death. 90% of patients died within 3 years after diagnosis. Lung cancer is the growth of cancer cells that are not controlled in the lung tissue that can be caused by a number of environmental carcinogens, especially cigarette smoke. According to the World Health Organization (WHO), lung cancer is a major cause of death in the cancer group in both men and women.
Treatment or therapy at this time many have applied, but not all running with effective, many patients who come to the hospital in an advanced stage and only a few successful treatment, and of therapy used is a type of therapy experimental, meaning the use of the various possibilities. Because there is no therapy currently available that is absolutely effective in treating lung cancer, patients may be offered a number of new therapies that are still in experimental status, which means that doctors do not yet have enough information to decide whether these therapies must be the forms received to treat lung cancer.
New drugs or new combinations of drugs were tested in the so-called clinical trials, which are studies that evaluate the effectiveness of new treatments compared with treatments that have been used extensively. Experimental treatments, known as immunotherapy’s being studied which involves the use of therapies associated with vaccines or other therapies that attempt to use the body’s immune system to fight cancer cells.
Lung tumors can be prevented or reduced the risk factors in three ways, namely primary prevention, secondary, and tertiary. Primary prevention can be done to prevent someone from becoming smokers. Secondary prevention is the cessation of active smokers. Meanwhile, tertiary prevention to find people with early-stage lung cancer.
Prepared from various sources …
